Get the Stockscreener App
10.11
0.40%
0.0455
Embecta Corp stock is traded at $10.11, with a volume of 509.85K.
It is up +0.40% in the last 24 hours and down -21.40% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$10.06
Open:
$10.19
24h Volume:
509.85K
Relative Volume:
0.75
Market Cap:
$598.71M
Revenue:
$1.10B
Net Income/Loss:
$83.60M
P/E Ratio:
7.0668
EPS:
1.43
Net Cash Flow:
$132.30M
1W Performance:
-3.53%
1M Performance:
-21.40%
6M Performance:
-24.17%
1Y Performance:
-39.23%
1-Day Range:
$10.01
$10.39
1-Week Range:
$9.95
$11.07
52-Week Range:
$9.20
$16.75
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
10.11 | 595.75M | 1.10B | 83.60M | 132.30M | 1.43 |
|
ISRG
Intuitive Surgical Inc
|
479.82 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
178.38 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.61 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
43.86 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
246.69 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance
Embecta names CEO Kurdikar as new board chair, picks new lead independent director - Drug Delivery Business
Embecta Corp. Appoints Devdatt Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director - Quiver Quantitative
embecta CEO Dev Kurdikar adds chair role as Pomeroy becomes lead director - Stock Titan
Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15 - Yahoo Finance
Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction - MSN
Embecta (NASDAQ:EMBC) Trading Down 5%Should You Sell? - MarketBeat
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Why analysts remain bullish on Embecta Corp. stock2025 Earnings Impact & AI Based Buy/Sell Signal Reports - mfd.ru
Trading the Move, Not the Narrative: (EMBC) Edition - Stock Traders Daily
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15 - simplywall.st
Embecta Earnings Call: U.S. Headwinds, Global Offsets - TipRanks
3 Healthcare Stocks Paying the Highest Dividends of 2026 - The Motley Fool
Embecta: Stable Execution, GLP-1–Driven Growth Optionality, and Attractive Valuation Support Buy Rating and $25 Target - TipRanks
BTIG Research Reiterates "Buy" Rating for Embecta (NASDAQ:EMBC) - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG Reiterates Buy Rating on Embecta (EMBC) with Stable Price T - GuruFocus
Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline By Investing.com - Investing.com South Africa
Embecta Corp. (EMBC) Stock Analysis: Navigating a 59% Potential Upside Amid Healthcare Innovations - DirectorsTalk Interviews
Embecta (EMBC) Margin Rebound And 4.4x P E Challenge Cautious Narratives - Sahm
Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline - Investing.com Nigeria
Embecta Corp. (NASDAQ:EMBC) to Issue $0.15 Quarterly Dividend - MarketBeat
Embecta Q1 Earnings Call Highlights - MarketBeat
Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges By GuruFocus - Investing.com Canada
Embecta reports Q1 adjusted EPS 71c, consensus 67c - TipRanks
Embecta (NASDAQ:EMBC) Releases Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Embecta Q1 2026 Earnings Call Transcript - MarketBeat
Embecta Corp. SEC 10-Q Report - TradingView
Revenue Check: What is the PEG ratio of Embecta CorpQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Embecta (NASDAQ:EMBC) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Embecta stock ticks up on Street-beating Q1 - Drug Delivery Business
Embecta (EMBC) Q1 2026 Earnings Call Transcript - The Globe and Mail
EMBC: Q1 revenue met expectations; U.S. headwinds offset by international growth and GLP-1 progress - TradingView
Earnings call transcript: Embecta Q1 2026 beats earnings estimates, stock rises - Investing.com India
Embecta (NASDAQ:EMBC) Issues FY 2026 Earnings Guidance - MarketBeat
Embecta earnings beat by $0.04, revenue topped estimates - Investing.com
Embecta Corp (NASDAQ:EMBC) Stock Falls 6.5% on Q1 Revenue Miss Despite EPS Beat - ChartMill
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results - TradingView
EMBECTA ($EMBC) Releases Q1 2026 Earnings - Quiver Quantitative
Embecta Q1 Earnings Summary & Key Takeaways - Benzinga
embecta Announces Quarterly Cash Dividend - Bluefield Daily Telegraph
Embecta Announces Quarterly Cash Dividend - marketscreener.com
A Look Into Embecta Inc's Price Over Earnings - Benzinga
Yacktman Asset Management LP Has $30.93 Million Stake in Embecta Corp. $EMBC - MarketBeat
Embecta shares tumble 49% after InvestingPro’s overvalued warning By Investing.com - Investing.com India
Quarterly Earnings: Will Embecta Corp stock go up in YEARJuly 2025 Catalysts & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Embecta (EMBC) Projected to Post Quarterly Earnings on Thursday - MarketBeat
(EMBC) Volatility Zones as Tactical Triggers - Stock Traders Daily
Teacher Retirement System of Texas Buys 292,477 Shares of Embecta Corp. $EMBC - MarketBeat
Embecta (NASDAQ:EMBC) Stock Price Down 6.3%Should You Sell? - MarketBeat
Big Picture: Is Embecta Corp forming a double bottomRate Cut & Weekly Stock Breakout Alerts - baoquankhu1.vn
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Embecta Corp Stock (EMBC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Melcher David F | Director |
Feb 25 '25 |
Buy |
13.67 |
13,000 |
177,646 |
76,681 |
| Morris Milton Mayo | Director |
Feb 13 '25 |
Sale |
16.38 |
3,100 |
50,783 |
36,133 |
5.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):